| scholarly article | Q13442814 |
| P2093 | author name string | Liu J | |
| Yoshida K | |||
| Zhang L | |||
| Rosenberg RD | |||
| P2860 | cites work | Heparan sulfate proteoglycans of the cardiovascular system. Specific structures emerge but how is synthesis regulated? | Q24561731 |
| Molecular cloning and expression of mouse and human cDNAs encoding heparan sulfate D-glucosaminyl 3-O-sulfotransferase | Q28114813 | ||
| Substrate specificity of heparanases from human hepatoma and platelets | Q28276774 | ||
| Purification of heparan sulfate D-glucosaminyl 3-O-sulfotransferase | Q28295437 | ||
| Patterns of sulphation in heparan sulphate: polymorphism based on a common structural theme | Q28318617 | ||
| Direct evidence for a predominantly exolytic processive mechanism for depolymerization of heparin-like glycosaminoglycans by heparinase I. | Q32068517 | ||
| Cell mutants defective in synthesizing a heparan sulfate proteoglycan with regions of defined monosaccharide sequence | Q33926104 | ||
| Evaluation of critical groups required for the binding of heparin to antithrombin | Q36248809 | ||
| Evidence for a 3-O-sulfated D-glucosamine residue in the antithrombin-binding sequence of heparin | Q36414932 | ||
| Biosynthesis of heparin and heparan sulfate | Q38254101 | ||
| Characterization of heparan sulfate oligosaccharides that bind to hepatocyte growth factor | Q38288128 | ||
| Age-dependent modulation of heparan sulfate structure and function | Q38337039 | ||
| Structural modification of fibroblast growth factor-binding heparan sulfate at a determinative stage of neural development | Q38339362 | ||
| Structural variation in the antithrombin III binding site region and its occurrence in heparin from different sources | Q38340870 | ||
| Structural requirement of heparan sulfate for interaction with herpes simplex virus type 1 virions and isolated glycoprotein C. | Q38342862 | ||
| Characterization of heparin and heparan sulfate domains binding to the long splice variant of platelet-derived growth factor A chain | Q38348282 | ||
| Contribution of monosaccharide residues in heparin binding to antithrombin III. | Q38351817 | ||
| Sequence variation in heparin octasaccharides with high affinity for antithrombin III. | Q38353259 | ||
| An animal cell mutant defective in heparan sulfate hexuronic acid 2-O-sulfation | Q38355072 | ||
| Role of endothelial cell surface heparin-like polysaccharides | Q38647598 | ||
| Evidence for degradation of heparan sulfate by endoglycosidases: Glucosamine and hexuronic acid are reducing terminals of intracellular heparan sulfate from human skin fibroblasts | Q39765263 | ||
| Differential interactions of heparin and heparan sulfate glycosaminoglycans with the selectins. Implications for the use of unfractionated and low molecular weight heparins as therapeutic agents | Q39799215 | ||
| Cyclic AMP inhibits synthesis of prostaglandin endoperoxide (PGG2) in human platelets | Q39977713 | ||
| Expression of the mouse mastocytoma glucosaminyl N-deacetylase/ N-sulfotransferase in human kidney 293 cells results in increased N-sulfation of heparan sulfate | Q41204799 | ||
| Lysolecithin-induced alteration of subendothelial heparan sulfate proteoglycans increases monocyte binding to matrix | Q41259574 | ||
| Molecular organization of heparan sulphate from human skin fibroblasts | Q41975008 | ||
| Sulphated and undersulphated heparan sulphate proteoglycans in a Chinese hamster ovary cell mutant defective in N-sulphotransferase | Q42010176 | ||
| Domain structure of heparan sulfates from bovine organs | Q42555942 | ||
| The disaccharide composition of heparins and heparan sulfates | Q43545252 | ||
| Turnover of heparan sulfate depends on 2-O-sulfation of uronic acids | Q46699156 | ||
| Identification and expression in mouse of two heparan sulfate glucosaminyl N-deacetylase/N-sulfotransferase genes | Q48037516 | ||
| Characterization of specific receptors for vasopressin in the pituitary gland | Q48738342 | ||
| Developmental Regulation of Neural Response to FGF-1 and FGF-2 by Heparan Sulfate Proteoglycan | Q52225676 | ||
| Heparan sulfate undergoes specific structural changes during the progression from human colon adenoma to carcinoma in vitro. | Q53437765 | ||
| Low-sulphated oligosaccharides derived from heparan sulphate inhibit normal angiogenesis. | Q54647861 | ||
| Characterization of a platelet endoglycosidase degrading heparin-like polysaccharides | Q71468428 | ||
| The putative heparin-specific N-acetylglucosaminyl N-Deacetylase/N-sulfotransferase also occurs in non-heparin-producing cells | Q77126990 | ||
| The retinoic acid and cAMP-dependent up-regulation of 3-O-sulfotransferase-1 leads to a dramatic augmentation of anticoagulantly active heparan sulfate biosynthesis in F9 embryonal carcinoma cells | Q77419023 | ||
| P433 | issue | 9 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | anticoagulant | Q215118 |
| embryonal carcinoma | Q1451877 | ||
| anticoagulation | Q63279445 | ||
| P304 | page(s) | 5681-5691 | |
| P577 | publication date | 1999-02-01 | |
| P1433 | published in | Journal of Biological Chemistry | Q867727 |
| P1476 | title | Anticoagulant heparan sulfate precursor structures in F9 embryonal carcinoma cells | |
| P478 | volume | 274 |
| Q37784309 | Anticoagulant heparan sulfate to not clot--or not? |
| Q34220892 | Biosynthesis of 3-O-sulfated heparan sulfate: unique substrate specificity of heparan sulfate 3-O-sulfotransferase isoform 5. |
| Q34464575 | Cell surface heparan sulfate and its roles in assisting viral infections |
| Q79260067 | Determining Heparan Sulfate Structure in the Vicinity of Specific Sulfotransferase Recognition Sites by Mass Spectrometry |
| Q35591462 | Directing the biological activities of heparan sulfate oligosaccharides using a chemoenzymatic approach |
| Q33878520 | Diversity and functions of glycosaminoglycan sulfotransferases |
| Q34016310 | Glycosaminoglycans in Human and Bovine Serum: Detection of Twenty-Four Heparan Sulfate and Chondroitin Sulfate Motifs Including a Novel Sialic Acid-modified Chondroitin Sulfate Linkage Hexasaccharide |
| Q33690545 | Heparan sulfate 3-O-sulfation: a rare modification in search of a function. |
| Q24302044 | Heparan sulfate 3-O-sulfotransferase isoform 5 generates both an antithrombin-binding site and an entry receptor for herpes simplex virus, type 1 |
| Q28141121 | Heparan sulfate D-glucosaminyl 3-O-sulfotransferase-3A sulfates N-unsubstituted glucosamine residues |
| Q36940425 | Human follicular fluid heparan sulfate contains abundant 3-O-sulfated chains with anticoagulant activity |
| Q29041315 | Mice deficient in heparan sulfate 3-O-sulfotransferase-1: Normal hemostasis with unexpected perinatal phenotypes |
| Q42920312 | Modification degrees at specific sites on heparan sulphate: an approach to measure chemical modifications on biological molecules with stable isotope labelling |
| Q41991496 | Modification of plasma glycosaminoglycans in long distance runners |
| Q33546538 | Screening for anticoagulant heparan sulfate octasaccharides and fine structure characterization using tandem mass spectrometry |
| Q34944523 | Sulfotransferases and sulfated oligosaccharides |
| Q29041276 | Synthesis of Anticoagulantly Active Heparan Sulfate Proteoglycans by Glomerular Epithelial Cells Involves Multiple 3-O-Sulfotransferase Isoforms and a Limiting Precursor Pool |
| Q33948367 | The effect of precursor structures on the action of glucosaminyl 3-O-sulfotransferase-1 and the biosynthesis of anticoagulant heparan sulfate |
Search more.